IDXX
2026Q1BMOIDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS3.41
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move3.6%
IV front—
P/C full—
P/C front—
Features as of2026-05-04
Run-up
Close—
Ret 5d-2.1%
Ret 10d-3.4%
Ret 20d-2.5%
Ret 30d-2.4%
Actual EPS
3.47Beat
Estimated EPS3.41
Actual revenue
1.1B
Surprise %+1.8%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction-1.1%
Implied vs actual
Implied 3.6%Actual 1.1%
Gap reaction+1.1%
Day result-0.0%
Next-day upNo
Realized / IV0.30×
Post tape
Post 5d-5.2%
Post 10d-2.9%
Post volume734.5K
Vol ×10d1.22×
Vol ×20d1.36×
Post range6.1%